QGIAX | VFINX | QGIAX / VFINX | |
Total Expense Ratio | 0.77 | 0.14 | 550% |
Annual Report Gross Expense Ratio | 1.27 | 0.14 | 907% |
Fund Existence | 34 years | 49 years | - |
Gain YTD | 7.115 | 10.110 | 70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 327M | 1.33T | 0% |
Annual Yield % from dividends | 0.62 | 1.09 | 57% |
Returns for 1 year | 1.22 | 16.72 | 7% |
Returns for 3 years | 24.03 | 50.29 | 48% |
Returns for 5 years | 39.59 | 91.84 | 43% |
Returns for 10 years | 58.15 | 208.47 | 28% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
KNSA | 33.38 | 0.10 | +0.30% |
Kiniksa Pharmaceuticals International plc | |||
EQH | 53.90 | -0.74 | -1.35% |
Equitable Holdings | |||
TCBX | 38.52 | -0.59 | -1.51% |
Third Coast Bancshares | |||
OTLK | 2.34 | -0.09 | -3.70% |
Outlook Therapeutics | |||
CDTG | 0.60 | -0.03 | -4.61% |
CDT Environmental Technology Investment Holdings Limited |